搜尋結果
3 天前 · Describe the basic physiology of alpha-adrenergic neural transmission. Report the basic principles of the use of alpha-adrenergic blockade in the treatment of BPH. Debate the presentation of mild to severe BPH for diagnosis. Detail the appropriate treatments for the various presentations of BPH.
4 天前 · Prazosin Taylor Fletcher, MD conducted a clinical trial of prazosin in order to explore the role of norepinephrine in the pathophysiology of ADHD and the potential mechanism of action of dextroamphetamine. Prazosin is an alpha-1 agonist.
2 天前 · On average, nearly 20 percent of participants in clinical trials for PTSD treatments drop out. Researchers think that number is most likely higher in practice and may be driven in part by patients ...
5 天前 · the effect of bradycardia on cardiac output is often underestimated. Bradycardia directly pulls down the cardiac output, potentially causing shock. Slowing down the heart rate may cause a minimal increase in diastolic filling, thereby increasing the stroke volume. However, this compensatory factor is weak and extremely limited.
4 天前 · Evidence-based interaction details between Prazosin (brand name (s): Minipress, Prazo, Prazin) and Magnesium, including interaction severity and how likely the interaction is to occur.
3 天前 · PRAZOSIN :: This is quinazoline derivative possessing a potent vasodilator action it has a specific a1-receptor blocking action however it appears that besides a1-blocking action it possess certain other properties that produce a potent vasodilator action it could be used alone in mild hypertension More often it is employed in combination with beta -adrenoceptor blockers or diuretics
3 天前 · Investigational MDMA-assisted therapy for posttraumatic stress disorder (PTSD) will be evaluated by the US Food and Drug Administration (FDA) Advisory Committee Meeting tomorrow on June 4, 2024. However, some clinicians are skeptical about its potential. We spoke to David N. Osser, MD, an expert on PTSD, about his thoughts on this treatment.
